Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticulate Systems For The Delivery Of Antisense Oligonucleotides.

G. Lambert, E. Fattal, P. Couvreur
Published 2001 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Antisense oligonucleotides are molecules that are able to inhibit gene expression being therefore potentially active for the treatment of viral infections or cancer. However, because of their poor stability in biological medium and their weak intracellular penetration, colloidal drugs carriers such as nanoparticles were developed for the delivery of oligonucleotides (ODN). ODN associated to nanoparticles were shown to be protected against degradation and to penetrate more easily into different types of cells. As a consequence, nanoparticles were shown to improve the efficiency of ODNs for the inhibition of the proliferation of cells expressing the point mutated Ha-ras gene. In vivo, polyalkylcyanoacrylate (PACA) nanoparticles were able to efficiently distribute the ODNs to the liver whereas the alginate nanosponges could concentrate the ODNs in the lungs. Finally, ODN loaded to PACA nanoparticles were able to improve in mice, the treatment of RAS cells expressing the point mutated Ha-ras gene.
This paper references
10.1016/0168-3659(85)90056-2
Preparation of injectable controlled-release microcapsules by a solvent-evaporation process
T. R. Tice (1985)
10.1128/AAC.35.4.770
Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis.
E. Fattal (1991)
10.1002/(SICI)1097-4628(19970919)65:12<2315::AID-APP6>3.0.CO;2-C
Emulsifier-free emulsion copolymerization of styrene with two different amino-containing cationic monomers. I. Kinetic studies
F. Ganachaud (1997)
10.1006/ABIO.1996.0350
Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier.
I. Aynié (1996)
10.1023/A:1018986226557
Preparation and Characterization of Novel Poly(methylidene Malonate 2.1.2.)-Made Nanoparticles
F. Lescure (2004)
10.1016/S0300-9084(99)80002-9
Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells.
G. Lambert (1998)
10.1002/JPS.2600750408
Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules.
J. Rollot (1986)
10.1016/0142-9612(84)90002-4
Degradation of poly (isobutyl cyanoacrylate) nanoparticles.
V. Lenaerts (1984)
10.1002/JPS.2600800117
Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice.
J. De Keyser (1991)
10.1002/JPS.2600730730
In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells.
V. Lenaerts (1984)
10.1126/SCIENCE.1279808
Stability and properties of double and triple helices: dramatic effects of RNA or DNA backbone composition.
R. Roberts (1992)
10.1016/0378-5173(92)90249-2
Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size
E. Allémann (1992)
10.1073/PNAS.85.18.6949
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
A. Gabizon (1988)
10.1006/JCIS.1997.5172
Cationic Polystyrene Nanoparticles: Preparation and Characterization of a Model Drug Carrier System for Antisense Oligonucleotides
Fritz (1997)
10.1007/0-306-46803-4_6
Poly(ethylene glycol)-coated nanospheres: potential carriers for intravenous drug administration.
R. Gref (1997)
10.3109/03639048609048026
Interfacial Polymerization, A Useful Method for the Preparation of Polymethylcyanoacrylate Nanoparticles
H. Krause (1986)
10.1093/INFDIS/168.1.164
Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue.
I. A. Bakker-Woudenberg (1993)
The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific.
Y. Castier (1998)
10.1002/JBM.820270807
Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.
T. Verrecchia (1993)
10.1126/SCIENCE.256.5064.1681
Triple helix-specific ligands.
J. Mergny (1992)
10.1016/0378-5173(90)90024-X
Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading
B. Seijo (1990)
10.1073/PNAS.86.10.3474
Characterization of oligonucleotide transport into living cells.
S. Loke (1989)
10.1073/PNAS.86.17.6454
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?
L. Yakubov (1989)
10.1006/JCIS.1998.5517
Effect of charge nature on the adsorption of single-stranded DNA fragments onto latex particles
A. Elaissari (1998)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.1016/S0024-3205(97)00539-0
Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.
M. Peracchia (1997)
10.1073/PNAS.88.24.11460
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
D. Papahadjopoulos (1991)
10.1023/A:1016017014573
Pharmacokinetics and Biodistribution of Oligonucleotide Adsorbed onto Poly(isobutylcyanoacrylate) Nanoparticles After Intravenous Administration in Mice
Y. Nakada (2004)
10.1016/S0168-3659(97)00246-0
Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides.
E. Fattal (1998)
10.1002/JPS.2600840420
Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
D. Bazile (1995)
10.1126/SCIENCE.8351515
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?
C. Stein (1993)
10.1089/OLI.1.1997.7.483
Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides.
H. Zobel (1997)
10.1016/0168-3659(89)90005-9
The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process
F. Koosha (1989)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1002/(SICI)1097-4636(19970305)34:3<317::AID-JBM6>3.0.CO;2-N
Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol).
M. Peracchia (1997)
10.1021/LA00004A036
Adsorption and desorption studies of polyadenylic acid onto positively charged latex particles
A. Elaïssari (1995)
10.1073/PNAS.91.22.10460
Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.
G. Schwab (1994)
10.1021/LA960896E
Adsorption of Single-Stranded DNA Fragments onto Cationic Aminated Latex Particles
F. Ganachaud (1997)
10.1126/SCIENCE.2003222
Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation.
P. Beal (1991)
10.1038/265407a0
Targeting of drugs
G. Gregoriadis (1977)
10.1111/J.1432-1033.1995.404ZZ.X
Antisense effects of cholesterol-oligodeoxynucleotide conjugates associated with poly(alkylcyanoacrylate) nanoparticles.
G. Godard (1995)
10.3109/10717549609029449
Encapsulation of oligonucleotides in stealth Me.PEG-PLA50 nanoparticles by complexation with structured oligopeptides.
Carole Emile (1996)
10.1016/S0966-842X(98)01438-3
CpG DNA: a novel immunomodulator.
A. Krieg (1999)
10.1016/0927-7757(93)02664-Z
Adsorption of oligonucleotides onto negatively and positively charged latex particles
A. Elaissari (1994)
10.1016/S0006-2952(97)00214-1
Antisense oligonucleotides: is the glass half full or half empty?
C. Bennett (1998)
10.1038/sj.bjp.0701396
Anti‐inflammatory activity of cationic lipids
M. Filion (1997)
10.1002/JPS.2600651217
Polymerized micelles and their use as adjuvants in immunology.
G. Birrenbach (1976)
10.1038/355850A0
Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures
A. Ellington (1992)
10.1002/(SICI)1097-4628(19970919)65:12<2331::AID-APP7>3.0.CO;2-A
Emulsifier-free emulsion copolymerization of styrene with two different amino-containing monomers: II. Surface and colloidal characterization
F. Sauzedde (1997)
10.1089/OLI.1.1999.9.301
Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides.
I. Aynié (1999)
10.1096/fasebj.7.6.7682523
Progress toward oligonucleotide therapeutics: pharmacodynamic properties
S. Crooke (1993)
10.1007/978-1-4615-6405-8_14
Nanoparticles as Carriers for Antisense Oligonucleotides
O. Balland (1996)
10.1038/374546A0
CpG motifs in bacterial DNA trigger direct B-cell activation
Arthur M. Krieg (1995)
10.1002/JPS.2600781215
New method for the preparation of cyanoacrylic nanoparticles with improved colloidal properties.
V. Lenaerts (1989)
10.1016/0378-5173(92)90248-Z
Aqueous nanodispersions prepared by a salting-out process
H. Ibrahim (1992)
10.1002/PAT.1995.220060709
Preparation and characterization of cationic polystyrene latex particles of different aminated surface charges
F. Ganachaud (1995)
10.1093/NAR/22.19.3943
Recognition and cleavage of hairpin structures in nucleic acids by oligodeoxynucleotides.
J. François (1994)
10.1089/ARD.1994.4.201
Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey.
W. M. Galbraith (1994)
10.1073/PNAS.92.9.4051
The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
T. Burgess (1995)
10.1093/ANNONC/5.SUPPL_4.S55
An approach for new anticancer drugs: oncogene-targeted antisense DNA.
G. Schwab (1994)
10.1016/0378-5173(93)90265-H
Development of poly (dialkyl methylidenemalonate) nanoparticles as drug carriers
T.K.M. T.K.M. Mbela (1993)
10.1126/SCIENCE.1279811
Antisense and antigene properties of peptide nucleic acids.
J. Hanvey (1992)
10.1023/A:1016366022712
Molecular Weights of Free and Drug-Loaded Nanoparticles
Luc Vansnick (2004)



This paper is referenced by
10.1186/1471-2105-8-365
Computational genes: a tool for molecular diagnosis and therapy of aberrant mutational phenotype
I. Martínez-Pérez (2007)
10.1002/9781118229347.CH5
Nanotechnology‐Enabled Delivery Systems for Food Functionalization and Fortification
Rashmi Tiwari (2012)
UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE FARMÁCIA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS Nanoemulsões catiônicas como sistemas de liberação de oligonucleotídeos: Formulação e caracterização físico-química
P. Alegre (2005)
10.1201/9781420006636.CH15
Poly(Alkyl Cyanoacrylate) Nanoparticles for Delivery of Anti-Cancer Drugs
R. R. Murthy (2006)
10.1002/JPS.21211
Liposomes incorporating a Plasmodium amino acid sequence target heparan sulfate binding sites in liver.
R. Robertson (2008)
10.1016/J.TRAC.2015.06.014
PLGA-based nanoparticles: A new paradigm in biomedical applications
Shweta R. Sharma (2016)
10.1163/156856208786140382
Synthesis and colon-specific drug delivery of a poly(acrylic acid-co-acrylamide)/MBA nanosized hydrogel
Debajyoti Ray (2008)
10.1016/S0076-6879(04)87013-7
Requirements for delivery of active antisense oligonucleotides into cells with lipid carriers.
I. Jääskeläinen (2004)
Title DNA-based nano-sized systems for pharmaceutical and biomedical applications
Sakulrat Rattanakiat (2017)
10.1016/S0303-2647(02)00010-2
From molecular biology to nanotechnology and nanomedicine.
K. Bogunia-Kubik (2002)
10.1002/JBM.A.31584
Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.
Zengshuan Ma (2008)
10.1002/ANIE.200602779
Degradable polyelectrolyte capsules filled with oligonucleotide sequences.
A. Zelikin (2006)
10.1002/9780470571224.PSE301
Stability Assessment and Formulation Characterization
Albert Hee Lum Chow (2010)
10.3329/IJPLS.V2I3.15457
Drug Delivery to The Brain Using Polymeric Nanoparticles: A Review
Bhatt Neha (2013)
10.1007/3-540-26809-X_1
Oligonucleotides as radiopharmaceuticals.
B. Tavitian (2005)
10.1007/978-3-030-34475-7_16
Metal- and Polymer-Based Nanoparticles for Advanced Therapeutic and Diagnostic System Applications
Nicole Bassous (2020)
10.23860/diss-wang-zimeng-2016
Dry Powder Aerosol Nanocomposite Microparticles for the Treatment of Pulmonary Diseases
Zimeng Wang (2016)
10.1016/j.jconrel.2008.12.018
Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
R. C. Nagarwal (2009)
Increasing the yield of iron-dextran nanoparticles by ultrasonic treatment
X. Gao (2019)
10.18433/J3SW2T
Preparation and Physicochemical Characterization of Eudragit ® RL100 Nanosuspension with potential for Ocular Delivery of Sulfacetamide
Bivash Mandal (2010)
10.22159/AJPCR.2018.V11I1.22035
NANOPARTICLES: A PROMISING DRUG DELIVERY APPROACH
R. Kadian (2018)
10.1201/9781420004014.CH23
Nanoparticles for Drug Delivery
A. Lowman (2006)
10.1070/RC2012V081N01ABEH004219
Nanoemulsions: the properties, methods of preparation and promising applications
M. Koroleva (2012)
DIFFERENT TECHNIQUES FOR PREPARATION OF POLYMERIC NANOPARTICLES-A
H. K. Yadav (2012)
10.1046/J.1432-1033.2002.03299.X
Optimizing the delivery systems of chimeric RNA.DNA oligonucleotides.
Li Liang (2002)
A NANOSCALE POLYNUCLEOTIDE-NEUTRAL LIPOSOME SELF-ASSEMBLIES FORMULATED FOR THERAPEUTIC GENE DELIVERY
C. Científico (2004)
10.1016/B978-012370615-7/50039-1
Chapter Thirty-Five – Gene Delivery into Cells and Tissues
Prokop Ales (2007)
10.3109/02652040802500622
Biodegradable alginate microparticles developed by electrohydrodynamic spraying techniques for oral delivery of protein
Tittaya Suksamran (2009)
10.1201/9780203912072.ch18
New experimental therapeutic approaches for degenerative diseases of the retina
J. Tombran-tink (2003)
10.1093/CLINCHEM/48.4.665
Effects of anticoagulant and time of plasma separation on measurement of homocysteine.
N. Duarte (2002)
10.1016/S1748-0132(08)70040-9
Nanoparticle-modified polyelectrolyte capsules
P. Gil (2008)
10.1088/1748-6041/10/4/045016
An in vitro study of peptide-loaded alginate nanospheres for antagonizing the inhibitory effect of Nogo-A protein on axonal growth.
Peng Zhai (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar